---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-079152"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2026-02-27T23:59:59+00:00"
generated_at: "2026-05-15T23:05:32.548311+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Fulgent Genetics Q4 2025 revenue $83.3M (+9% YoY); GAAP loss $0.76/share, Non-GAAP income $0.16/share

## Summary
- Q4 2025 revenue of $83.3M, up 9% year-over-year; full-year revenue $322.7M, up 14%.
- GAAP net loss $23.4M ($0.76 loss per share) in Q4; full-year GAAP loss $60.5M ($1.97 per share).
- Non-GAAP net income $5.2M ($0.16 per share) in Q4; full-year non-GAAP income $13.2M ($0.42 per share).
- Cash, equivalents, restricted cash, and marketable securities totaled $705.5M at year-end, plus $106.3M anticipated tax refund.
- Adjusted EBITDA loss of $4.5M in Q4 and $9.4M for full year 2025.

## SEC filing metadata
- accession: 0001193125-26-079152
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2026-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079152/0001193125-26-079152-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000119312526079152/flgt-20260227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-079152
- JSON: https://secwatch.observer/filing/0001193125-26-079152.json
- Plain text: https://secwatch.observer/filing/0001193125-26-079152.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.